• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Antipsychotic Injections Linked to a Sharp Drop in Hospital Readmissions

Antipsychotic Injections Linked to a Sharp Drop in Hospital Readmissions

by William Jester | Mar 16, 2024 | Community, News

Antipsychotic injections upon hospital discharge were associated with a 75 percent reduction in 30-day rehospitalizations when compared with oral antipsychotics, according to a Rutgers Health study. The findings, published in the Journal of Clinical...

Spring 2024 LEARNING MENTORING, Tuesday 3/19-5/7, 10-11am

by Pamela Dahlen | Mar 15, 2024 | News

Are you a STEM grad student or postdoc, and committed to becoming an effective mentor? Join a virtual cohort of like-minded peers! A major component of many careers — both within and beyond the academy — is mentoring trainees, yet graduate students and...
NJACTS Community Engagement Core COVID-19 Resources

NJACTS Community Engagement Core COVID-19 Resources

by William Jester | Mar 15, 2024 | Community, Covid, News

The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...
Rutgers Cancer Institute of New Jersey Retains Position as the State’s Only Designated Comprehensive Cancer Center.

Rutgers Cancer Institute of New Jersey Retains Position as the State’s Only Designated Comprehensive Cancer Center.

by William Jester | Mar 15, 2024 | Community, News

Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, has been redesignated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center, placing it among the top centers in the country reviewed in 2023. The designation from the NCI,...

The New Jersey Commission on Spinal Cord Research 2025 Grant Cycle – $6M in Funding Available

by Pamela Dahlen | Mar 14, 2024 | News

The Research Program Guidelines for the 2025 Grant Cycle is located on the New Jersey Commission on Spinal Cord Research website at: https://www.nj.gov/health/spinalcord/ For all grant categories, applicants must complete an online application.  Online applications...
« Older Entries
Next Entries »

Recent Posts

  • Extreme Monsoon Changes Threaten the Bay of Bengal’s Role as a Critical Food Source.
  • New NJACTS Publication
  • Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on June 19th
  • NJIT Study Probes Genetic ‘Smoking Gun,’ Health Risks of Vaping Among Gen Z.
  • Measles cases seem to be slowing down in the US. What’s behind it?

Archives

  • 2025
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,270)
  • Covid (986)
  • CTO Events (6)
  • News (2,892)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.